Experience with non-drug strategies in women with metabolic syndrome during the menopausal transition: a focus on cardiovascular risk

R. Berikhanova, I. Minenko, S. А. Bondarev
{"title":"Experience with non-drug strategies in women with metabolic syndrome during the menopausal transition: a focus on cardiovascular risk","authors":"R. Berikhanova, I. Minenko, S. А. Bondarev","doi":"10.32948/ajpt.2021.03.10","DOIUrl":null,"url":null,"abstract":"Background A decline in the quality of life of mature women, a high prevalence of metabolic syndrome in them, restrictions on the use of hormonal therapy form the need to search for effective and safe methods aimed at reducing the risk of cardiovascular complications and relieving climacteric disorders.\nMethods The possibilities of non-drug correction (standard approach, physiotherapy, balneotherapy, multivitamins and minerals, physiotherapy) of metabolic and endocrine disorders in 330 women 45-50 years old with metabolic syndrome (MS) during menopause were studied. The participants were divided into 5 groups depending on the programs used, 2 subgroups - mild and moderate menopausal syndrome (MPS). The levels of follicle-stimulating (FSH), luteinizing (LH) hormones, estradiol, hemostasis, glycemic status, lipid profile, green test, blood pressure (BP), SCORE scale were assessed.\nResults In patients with mild MPS, when using programs with physiotherapy, HOMA-IR decreased by 50%, the atherogenic index by more than 25.0%, INR increased by more than 4,0%, the Green score decreased by more than 40.0%, the risk on a SCORE scale became <3%. In patients with moderate MPS, the treatment complex with the simultaneous use of vibrotherapy, chromotherapy, melootherapy, aromatherapy and aeroionotherapy had the advantage: HOMA-IR decreased by 50.5%, atherogenic index by 30,5%, INR increased by 5.0%, the Green score decreased by 40.0%, the risk on a SCORE scale became <3%.\nConclusions In patients with MPS and MS, non-drug programs using physical therapy have a positive effect on the functioning of the endocrine system, hemostasis, carbohydrate and fat metabolism which helps reduce the risk of cardiovascular events. In case of moderate MPS against the background of MS, the program with simultaneous use of vibrotherapy, chromotherapy, melotherapy, aromatherapy and aeroionotherapy has an advantage.","PeriodicalId":139487,"journal":{"name":"Asia-Pacific Journal of Pharmacotherapy & Toxicology","volume":"38 3","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific Journal of Pharmacotherapy & Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32948/ajpt.2021.03.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background A decline in the quality of life of mature women, a high prevalence of metabolic syndrome in them, restrictions on the use of hormonal therapy form the need to search for effective and safe methods aimed at reducing the risk of cardiovascular complications and relieving climacteric disorders. Methods The possibilities of non-drug correction (standard approach, physiotherapy, balneotherapy, multivitamins and minerals, physiotherapy) of metabolic and endocrine disorders in 330 women 45-50 years old with metabolic syndrome (MS) during menopause were studied. The participants were divided into 5 groups depending on the programs used, 2 subgroups - mild and moderate menopausal syndrome (MPS). The levels of follicle-stimulating (FSH), luteinizing (LH) hormones, estradiol, hemostasis, glycemic status, lipid profile, green test, blood pressure (BP), SCORE scale were assessed. Results In patients with mild MPS, when using programs with physiotherapy, HOMA-IR decreased by 50%, the atherogenic index by more than 25.0%, INR increased by more than 4,0%, the Green score decreased by more than 40.0%, the risk on a SCORE scale became <3%. In patients with moderate MPS, the treatment complex with the simultaneous use of vibrotherapy, chromotherapy, melootherapy, aromatherapy and aeroionotherapy had the advantage: HOMA-IR decreased by 50.5%, atherogenic index by 30,5%, INR increased by 5.0%, the Green score decreased by 40.0%, the risk on a SCORE scale became <3%. Conclusions In patients with MPS and MS, non-drug programs using physical therapy have a positive effect on the functioning of the endocrine system, hemostasis, carbohydrate and fat metabolism which helps reduce the risk of cardiovascular events. In case of moderate MPS against the background of MS, the program with simultaneous use of vibrotherapy, chromotherapy, melotherapy, aromatherapy and aeroionotherapy has an advantage.
绝经过渡期代谢综合征妇女的非药物治疗经验:关注心血管风险
背景:成熟女性生活质量的下降,代谢综合征的高发,激素治疗的使用受到限制,需要寻找有效和安全的方法来降低心血管并发症的风险,缓解更年期紊乱。方法对330例45 ~ 50岁绝经期代谢综合征(MS)妇女进行非药物矫正(标准方法、物理疗法、按摩疗法、多种维生素和矿物质疗法、物理疗法)治疗代谢和内分泌紊乱的可能性进行分析。参与者根据所使用的方案分为5组,2个亚组-轻度和中度更年期综合征(MPS)。评估促卵泡激素(FSH)、促黄体生成素(LH)、雌二醇、止血、血糖状态、血脂、绿色试验、血压(BP)、SCORE量表水平。结果在轻度MPS患者中,当使用物理治疗方案时,HOMA-IR下降50%,动脉粥样硬化指数下降超过25.0%,INR增加超过4,0%,Green评分下降超过40.0%,score量表上的风险变为<3%。在中度MPS患者中,同时使用振动疗法、颜色疗法、皮肤疗法、芳香疗法和空气离子疗法的治疗组合具有优势:HOMA-IR降低50.5%,动脉粥样硬化指数降低30.5%,INR增加5.0%,Green评分降低40.0%,score量表上的风险变为<3%。结论在MPS和MS患者中,非药物方案采用物理治疗对内分泌系统功能、止血、碳水化合物和脂肪代谢有积极作用,有助于降低心血管事件的风险。对于多发性硬化症背景下的中度MPS,同时使用振动疗法、色光疗法、美洛疗法、芳香疗法和空气离子疗法的方案具有优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信